Polyethylene glycol
( DrugBank: Polyethylene glycol / KEGG DRUG: Polyethylene glycol 3350, Macrogol 4000, Macrogol 6000 )
4 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
50 | Dermatomyositis | 1 |
97 | Ulcerative colitis | 7 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
195 | Noonan syndrome | 1 |
299 | Cystic fibrosis | 3 |
50. Dermatomyositis
Clinical trials : 231 / Drugs : 216 - (DrugBank : 55) / Drug target genes : 59 - Drug target pathways : 141
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
97. Ulcerative colitis
Clinical trials : 3,305 / Drugs : 1,646 - (DrugBank : 318) / Drug target genes : 165 - Drug target pathways : 220
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
195. Noonan syndrome
Clinical trials : 38 / Drugs : 27 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 96
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
299. Cystic fibrosis
Clinical trials : 1,826 / Drugs : 1,271 - (DrugBank : 246) / Drug target genes : 118 - Drug target pathways : 180
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|